SCHEMBL9364675

SCHEMBL9364675

CCC(=O)C(=O)Nc1cc(C(F)(F)F)c(Cl)cc1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.40
CYP3A4 P08684 3/20 0.40
ALDH1A1 P00352 2/20 0.40
ALOX15 P16050 2/20 0.40
TSHR P16473 2/20 0.40
LMNA P02545 2/20 0.40
MAPK1 P28482 2/20 0.40
CES2 O00748 1/20 0.40
ABCB11 O95342 1/20 0.40
CYP1A2 P05177 1/20 0.40
GLA P06280 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CHRM1 P11229 1/20 0.40
CYP2C9 P11712 1/20 0.40
TBXA2R P21731 1/20 0.40
AADAC P22760 1/20 0.40
CYP2C19 P33261 1/20 0.40
ADRA1A P35348 1/20 0.40
HTT P42858 1/20 0.40
HTR6 P50406 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9364681 0.86 GPR35 (0.55) ALDH1A1LMNASMN1; SMN2RECQLKMT2A
SCHEMBL9365098 0.85 RECQL (0.45) ALDH1A1LMNAMAPK1SMN1; SMN2RECQL
SCHEMBL8903432 0.85 AR (0.41) ARCYP3A4ALDH1A1ALOX15TSHR
SCHEMBL463022 0.84 NPSR1 (0.47) ARCYP3A4ALDH1A1ALOX15TSHR
SCHEMBL27615949 0.83 RORC (0.43) ARCYP3A4ALDH1A1ALOX15TSHR
SCHEMBL9364625 0.82 LMNA (0.48) ARCYP3A4ALDH1A1ALOX15TSHR
SCHEMBL31495022 0.82 AR (0.43) ARCYP3A4ALDH1A1ALOX15TSHR
SCHEMBL9364624 0.80 AR (0.39) ARCYP3A4ALDH1A1ALOX15TSHR
SCHEMBL5557086 0.79 AR (0.42) ARCYP3A4ALDH1A1ALOX15TSHR
SCHEMBL6607451 0.78 RORC (0.43) ARCYP3A4ALDH1A1ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP disclosed
US-5061706-A 2,3-QUINOXALINEDIONES FOR USE AS NEUROLEPTICS NOVO NORDISK A/S (DK) 1991-10-29 US disclosed
EP-0377112-A1 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1990-07-11 EP disclosed